Jason O'Rourke

Jason O'Rourke has significant experience in the field of pharmacology and drug discovery. Jason is currently the Director - Target Biology at Empirico Inc. since 2023. Prior to this, they served as the Director - Pharmacology at SNO bio, Inc. from 2022 to 2023.

Their previous role was the Associate Director - In Vivo Pharmacology at Fate Therapeutics Inc. where they led the in vivo pharmacology team in supporting the development of immuno-oncology cell therapy products. Their responsibilities included testing therapeutic hypotheses, conducting preclinical studies for IND enablement, and developing innovative in vivo models and technology platforms. Jason also managed collaborations with pharma partners and oversaw CRO management. Jason held this position from 2019 to 2022 and was previously a Senior Scientist - In Vivo Pharmacology at the same company from 2019 to 2020.

Before joining Fate Therapeutics Inc., Jason was a Group Leader - Drug Discovery Pharmacology at Sanford Burnham Prebys Medical Discovery Institute from 2016 to 2019. Jason also worked as a Research Fellow - Regenerative Medicine and Oncology at GNF from 2013 to 2016. Jason began their career as a Postdoctoral Scientist in the Olson Lab at The University of Texas Southwestern Medical Center at Dallas from 2009 to 2013.

Overall, Jason O'Rourke has a strong background in pharmacology, with expertise in in vivo studies, IND enablement, model development, and CRO management.

Jason O'Rourke attended the University of Florida from 2004 to 2009, where they pursued a Doctor of Philosophy (Ph.D.) degree in Molecular Genetics.